These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 3552596)
1. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Goa KL; Campoli-Richards DM Drugs; 1987 Mar; 33(3):242-58. PubMed ID: 3552596 [TBL] [Abstract][Full Text] [Related]
2. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Drake S; Lampasona V; Nicks HL; Schwarzmann SW Clin Pharm; 1985; 4(5):507-16. PubMed ID: 3902329 [TBL] [Abstract][Full Text] [Related]
3. Treatment of pneumocystis carinii pneumonia in children. Lipson A; Marshall WC; Hayward AR Arch Dis Child; 1977 Apr; 52(4):314-9. PubMed ID: 301010 [TBL] [Abstract][Full Text] [Related]
4. Update on pentamidine for the treatment of Pneumocystis carinii pneumonia. Salamone FR; Cunha BA Clin Pharm; 1988 Jul; 7(7):501-10. PubMed ID: 3046830 [TBL] [Abstract][Full Text] [Related]
5. Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Pearson RD; Hewlett EL Ann Intern Med; 1985 Nov; 103(5):782-6. PubMed ID: 3901852 [TBL] [Abstract][Full Text] [Related]
6. Pentamidine for the prevention and treatment of P. carinii pneumonia. Molavi A Am Fam Physician; 1989 Jul; 40(1):195-200. PubMed ID: 2662725 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine. Young RC; DeVita VT Natl Cancer Inst Monogr; 1976 Oct; 43():193-200. PubMed ID: 1087955 [TBL] [Abstract][Full Text] [Related]
8. Adverse effects associated with intravenous pentamidine isethionate as treatment of Pneumocystis carinii pneumonia in AIDS patients. Balslev U; Nielsen TL Dan Med Bull; 1992 Aug; 39(4):366-8. PubMed ID: 1526188 [TBL] [Abstract][Full Text] [Related]
9. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Montgomery AB; Debs RJ; Luce JM; Corkery KJ; Turner J; Brunette EN; Lin ET; Hopewell PC Lancet; 1987 Aug; 2(8557):480-3. PubMed ID: 2887779 [TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes during administration of pentamidine isethionate. Wharton JM; Demopulos PA; Goldschlager N Am J Med; 1987 Sep; 83(3):571-6. PubMed ID: 3499072 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ; Hauptman SP Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [TBL] [Abstract][Full Text] [Related]
12. Adverse reactions associated with pentamidine isethionate in AIDS patients: recommendations for monitoring therapy. Andersen R; Boedicker M; Ma M; Goldstein EJ Drug Intell Clin Pharm; 1986 Nov; 20(11):862-8. PubMed ID: 3490958 [TBL] [Abstract][Full Text] [Related]
13. [Pentamidine inhalation for Pneumocystis carinii pneumonia in AIDS]. Pines A; Giladi M; Moshkowitz M; Finkelstein A; Levo Y Harefuah; 1989 Mar; 116(6):311-2. PubMed ID: 2786489 [TBL] [Abstract][Full Text] [Related]
14. Pentamidine isethionate approved for P. carinii pneumonia. FDA Drug Bull; 1984 Dec; 14(3):25-6. PubMed ID: 6335442 [No Abstract] [Full Text] [Related]
15. Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia. Monk JP; Benfield P Drugs; 1990 May; 39(5):741-56. PubMed ID: 2191850 [TBL] [Abstract][Full Text] [Related]
16. Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Miller RF; Godfrey-Faussett P; Semple SJ Thorax; 1989 Jul; 44(7):565-9. PubMed ID: 2788936 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group. Siegel SE; Wolff LJ; Baehner RL; Hammond D Am J Dis Child; 1984 Nov; 138(11):1051-4. PubMed ID: 6388315 [TBL] [Abstract][Full Text] [Related]
18. Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. A pilot study. Conte JE; Hollander H; Golden JA Ann Intern Med; 1987 Oct; 107(4):495-8. PubMed ID: 3498418 [TBL] [Abstract][Full Text] [Related]
19. [Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome]. Höffken G; Elsing C; Ruhnke M; Franke M; Schrappe-Bächer M; Stellbrink HJ; Weiss R; Noack H; Petri M; Lode H Med Klin (Munich); 1990 Apr; 85 Suppl 2():281-5. PubMed ID: 2197538 [TBL] [Abstract][Full Text] [Related]
20. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia. Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]